Fifth Annual FDA-ISPE Quality Conference. The meeting will be held June 5-8, 2016 in Bethesda, MD.
Goals and Objectives:
FDA co-sponsorship of the conference(s) will ensure widespread opportunity for global regulatory agencies and industry leaders to engage in information dissemination, issue prioritization and consensus building to advance pharmaceutical and biotech product quality and manufacturing. Industry attendees will benefit by taking away practical approaches that can be implemented as best practices in their companies.
Who Should Attend:
This annual conference is intended for engineers, regulators, and scientists working in the areas of pharmaceutical quality, product development, manufacturing, and regulatory affairs. The topics for the conference are selected to meet the professional and scientific concerns that typify the work of global regulators and industry leaders in drug development, manufacturing, and quality. The session content will be developed so that individuals with varying years of experience can benefit from and contribute to the conference.
The primary audience includes academic, industrial, and regulatory experts. The audience should extend to pharmaceutical companies, regulatory agencies, non-profit organizations, and other healthcare sectors, drawing scientists and clinicians involved in drug development and regulatory decision in the US and abroad.
Contact
Harry Smith
301-796-4442